abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

Historical Holders from Q3 2014 to Q3 2025

Symbol
HQL on NYSE
Type / Class
Equity / Common Shares, $0.01 par value
Shares outstanding
28.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
9.14M
Holdings value
$141M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
81
Number of buys
45
Number of sells
-25
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Saba Capital Management, L.P. 7.88% -12% $39.8M -$5.46M 2.27M -12.1% Saba Capital Management, L.P. 21 Nov 2025
FIRST TRUST PORTFOLIOS LP 6.33% $23M 1.83M First Trust Portfolios L.P. 31 Mar 2025

Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 9.14M $141M -$612K $15.51 81
2025 Q2 9.16M $117M +$3.72M $12.81 75
2025 Q1 8.87M $113M -$7.77M $12.69 82
2024 Q4 9.48M $124M -$6.08M $13.12 72
2024 Q3 9.87M $149M +$3.5M $15.08 74
2024 Q2 9.61M $136M +$7.42M $14.17 75
2024 Q1 9.1M $124M +$15.5M $13.63 79
2023 Q4 7.96M $107M +$20.6M $13.46 79
2023 Q3 6.43M $80.2M +$11.3M $12.47 79
2023 Q2 5.5M $74.4M +$3.75M $13.54 78
2023 Q1 5.22M $72.7M +$182K $13.93 78
2022 Q4 5.22M $74.2M +$13.5M $14.21 79
2022 Q3 4.27M $58.4M +$8.41M $13.66 59
2022 Q2 3.67M $52.3M +$42.2K $14.23 63
2022 Q1 3.66M $60.6M -$3.86M $16.54 62
2021 Q4 3.87M $74.4M -$4.34M $19.23 62
2021 Q3 4.08M $85.1M -$6.8M $20.80 60
2021 Q2 4.39M $94.2M -$7.77M $21.44 62
2021 Q1 4.76M $93.8M -$3.06M $19.71 59
2020 Q4 4.9M $96.9M +$4.28M $19.75 61
2020 Q3 4.67M $82.1M +$2.72M $17.58 56
2020 Q2 4.59M $82.5M +$2.42M $17.96 65
2020 Q1 4.35M $65.2M +$3.31M $14.98 64
2019 Q4 4.08M $71.2M +$10.2M $17.43 62
2019 Q3 3.31M $50M +$2.02M $15.10 56
2019 Q2 3.17M $53.3M -$108K $16.85 50
2019 Q1 3.2M $54.7M -$880K $17.13 51
2018 Q4 3.26M $49.2M +$630K $15.11 53
2018 Q3 3.16M $64.6M -$621K $20.42 53
2018 Q2 3.2M $60.2M +$400K $18.79 57
2018 Q1 3.18M $60.9M +$2.12M $19.21 54
2017 Q4 3.06M $60M +$2.78M $19.63 53
2017 Q3 2.69M $57.9M +$5.15M $21.48 50
2017 Q2 2.45M $51.1M -$30.1K $20.85 43
2017 Q1 2.46M $47.6M -$1.65M $19.39 39
2016 Q4 2.57M $43.8M +$3.77M $16.99 44
2016 Q3 2.17M $40.7M -$925K $18.73 41
2016 Q2 2.23M $38.3M -$3.73M $17.19 46
2016 Q1 2.42M $43.4M -$4.2M $17.94 42
2015 Q4 2.62M $61.8M +$3.68M $23.64 46
2015 Q3 2.46M $55.6M +$3.05M $22.51 42
2015 Q2 2.3M $65M +$5.33M $28.21 41
2015 Q1 2.11M $58.2M -$948K $27.57 39
2014 Q4 2.15M $53.5M +$51.5M $24.88 38
2014 Q3 2.88K $64K +$64K $22.15 2